The growing interest in this medication, specifically the B974 formulation at 30mg, presents significant challenges within AU . While copyright is not available through official channels in AU , reports suggest its emergence on the grey market. This lack of authorized distribution fuels anxieties surrounding possible abuse , illegal trade, and the